Open AccessClinical Manifestations of COVID-19 Patients with Comorbid and Non-comorbid at Dr. Soetomo Hospital, Surabaya
Author(s) -
Erika Martining Wardani,
Riezky Faisal Nugroho,
Difran Nobel Bistara,
R. Khairiyatul Afiyah,
Siti Nur Hasina,
Yurike Septianingrum
Publication year - 2022
Publication title -
open access macedonian journal of medical sciences
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.288
H-Index - 17
ISSN - 1857-9655
DOI - 10.3889/oamjms.2022.7582
Subject(s) - medicine , nausea , anosmia , vomiting , comorbidity , medical record , covid-19 , diarrhea , emergency department , pediatrics , disease , psychiatry , infectious disease (medical specialty)
Background : Covid-19 has been declared a global health emergency. Reports of thousands of cases with morbidity and mortality continue to increase every day. The clinical course of patients with comorbidities influences the prognosis and progression of the covid-19 disease. Hypertension is the most common cormorbidity of covid-19 patients with long hospitalizations.
Objective : This study aimed to determine the clinical differences between covid-19 patients cormobid and non cormobid .
Methods : The study was conducted retrospectively through samples of medical records of inpatients for the period June 1, 2021 – August 31, 2021. The samples were divided into comorbid and non-cormobid groups; each totaling 130 medical records. The sample of the comorbid group was selected by simple random; while the non-cormobid group with the matching process. Data were analyzed using t-test and Wilcoxon.
Results : The most common kormobid is hypertension with clinical manifestations of cough, fever, headache, runny nose, painful swallowing, anosmia, shortness of breath, nausea, vomiting and diarrhea. The average length of stay for patients with comorbidities was 21 days and without comorbidities 14 days. The test results showed that there were clinical differences between patients with comorbid and non-cormobid patients with p value = 0.0000 (p>0.05) and there was a difference in length of stay with p-value = 0.001 (p>0.05).
Conclusion : The clinical difference between covid-19 patients comorbid and non cormobid lies in the symptoms of headache with a longer duration of treatment, which is 22 days. More intensive treatment and care is needed for covid-19 patients with comorbid hypertension.
Keywords : clinical manifestation; covid-19; comorbid; length of treatment.